Additional file 3: Figure S3. of GABPA predicts prognosis and inhibits metastasis of hepatocellular carcinoma

a There was no significant difference in tumor size between 7402-shGABPA and 7402-shCtrl groups. b Injection with SK-Hep1 GABPA-overexpressing cells dramatically decreased the number of metastatic tumors in the lungs and liver compared with those in the control. (*P < 0.05). (TIFF 13578 kb)